The earnings call reflects a predominantly positive outlook for Zimmer Biomet, with notable achievements in organic sales growth, strategic acquisitions, and positive guidance updates. Despite some challenges such as international order delays and tariff impacts, the company demonstrated strong performance in core areas and expressed high confidence in future growth driven by new product launches and strategic priorities.

Company Guidance -

Q3 2025

During the Zimmer Biomet Second Quarter 2025 Earnings Call, the company provided updated guidance for the fiscal year. Zimmer Biomet anticipates full-year organic constant currency revenue growth in the range of 3.5% to 4.5%, excluding the contribution from Paragon 28, and expects Paragon 28 to contribute 270 basis points to sales growth. The company revised its full-year adjusted earnings per share (EPS) guidance to $8.10 to $8.30, up from the previous range of $7.90 to $8.10. This updated guidance is driven by expected second-half sales acceleration, enhanced operational efficiency, reduced tariff impacts, and a favorable foreign exchange environment due to a weakening U.S. dollar. The guidance reflects confidence in new product introductions and strategic acquisitions, such as Monogram Technologies, which are expected to enhance Zimmer Biomet's position in the orthopedic market.

Solid Quarterly Performance

Zimmer Biomet delivered a solid quarter with sales growth of 2.8% on an organic constant currency basis, despite headwinds such as an 80 basis point selling day impact and international order delays.

Strong U.S. Hips and Knees Growth

U.S. Hips business grew 5.2% and U.S. Knees increased by 1.7%, showcasing strong domestic performance in these segments.

Updated Guidance and Confidence

Zimmer Biomet raised its 2025 adjusted EPS guidance to $8.10 to $8.30 from $7.90 to $8.10 and narrowed its organic constant currency revenue growth expectations to 3.5% to 4.5%.

Monogram Technologies Acquisition

Zimmer Biomet announced the acquisition of Monogram Technologies, a company with advanced AI-driven robotic capabilities, expected to be neutral to adjusted EPS from 2025 through 2027 and accretive thereafter.

Positive Pricing and Cash Flow Improvements

Consolidated pricing was positive, marking another quarter of positive pricing. Operating cash flows were $378 million, with free cash flow of $248 million, indicating strong cash management.

Zimmer Biomet Holdings (ZBH) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

ZBH Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 29, 2025	2025 (Q3)	1.88 / -	1.74	―	―	―
Aug 07, 2025	2025 (Q2)	1.98 / 2.07	2.01	2.99% (+0.06)	―
May 05, 2025	2025 (Q1)	1.77 / 1.81	1.94	-6.70% (-0.13)	―
Feb 06, 2025	2024 (Q4)	2.29 / 2.31	2.2	5.00% (+0.11)	―
Oct 30, 2024	2024 (Q3)	1.74 / 1.74	1.65	5.45% (+0.09)	―
Aug 07, 2024	2024 (Q2)	1.99 / 2.01	1.82	10.44% (+0.19)	―
May 02, 2024	2024 (Q1)	1.87 / 1.94	1.89	2.65% (+0.05)	―
Feb 08, 2024	2023 (Q4)	2.15 / 2.20	1.88	17.02% (+0.32)	―
Nov 07, 2023	2023 (Q3)	1.60 / 1.65	1.58	4.43% (+0.07)	―
Aug 01, 2023	2023 (Q2)	1.82 / 1.82	1.82	0.00% (0.00)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

ZBH Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$91.15	$98.43	+7.99%
May 05, 2025	$102.12	$90.24	-11.63%
Feb 06, 2025	$107.74	$102.20	-5.14%
Oct 30, 2024	$103.16	$109.05	+5.71%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Zimmer Biomet Holdings (ZBH) report earnings?

Zimmer Biomet Holdings (ZBH) is schdueled to report earning on Oct 29, 2025, Before Open (Confirmed).

What is Zimmer Biomet Holdings (ZBH) earnings time?

Zimmer Biomet Holdings (ZBH) earnings time is at Oct 29, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is ZBH EPS forecast?

ZBH EPS forecast for the fiscal quarter 2025 (Q3) is 1.88.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing